A beta-arrestin 2 signaling complex mediates lithium action on behavior.
Besides their role in desensitization, beta-arrestin 1 and 2 promote the formation of signaling complexes allowing G protein-coupled receptors (GPCR) to signal independently from G proteins. Here we show that lithium, a pharmacological agent used for the management of psychiatric disorders such as bipolar disorder, schizophrenia, and depression, regulates Akt/glycogen synthase kinase 3 (GSK3) signaling and related behaviors in mice by disrupting a signaling complex composed of Akt, beta-arrestin 2, and protein phosphatase 2A. When administered to beta-arrestin 2 knockout mice, lithium fails to affect Akt/GSK3 signaling and induce behavioral changes associated with GSK3 inhibition as it does in normal animals. These results point toward a pharmacological approach to modulating GPCR function that affects the formation of beta-arrestin-mediated signaling complexes.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
DOI
ISSN
Publication Date
Volume
Issue
Start / End Page
Location
Related Subject Headings
- beta-Arrestins
- beta-Arrestin 2
- beta-Arrestin 1
- Signal Transduction
- Receptors, G-Protein-Coupled
- Proto-Oncogene Proteins c-akt
- Protein Phosphatase 2
- Motor Activity
- Mood Disorders
- Mice, Knockout
Citation
Published In
DOI
ISSN
Publication Date
Volume
Issue
Start / End Page
Location
Related Subject Headings
- beta-Arrestins
- beta-Arrestin 2
- beta-Arrestin 1
- Signal Transduction
- Receptors, G-Protein-Coupled
- Proto-Oncogene Proteins c-akt
- Protein Phosphatase 2
- Motor Activity
- Mood Disorders
- Mice, Knockout